Fewer than half of adults have a follow-up colonoscopy within six months following an abnormal stool-based screening test (SBT) for colorectal cancer (CRC), according to a study published online March ...
FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...
Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...
A calprotectin stool test detects levels of calprotectin in stool. This protein indicates bowel inflammation. It can help diagnose and monitor conditions such as inflammatory bowel disease (IBD). A ...
What if you didn't have to get a colonoscopy every decade from ages 45 to 75? No, this isn't an excuse to skip screening for colon cancer, which has been proven to save lives. But there are several ...
Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...
When it comes to colon cancer screening, an annual stool test may be as effective as colonoscopy for people who don’t have risk factors for the disease, a new study suggests. Researchers analyzed data ...
In a new study aimed at identifying the best approach to promote colorectal cancer screening in adults aged 45 to 49, UCLA researchers found that simply mailing a stool-based test directly to people's ...
Colorectal cancer (CRC) is one of the most dreadful and commonly diagnosed cancers, claiming several lives worldwide. Regular screening is thus cardinal for timely diagnosis and treatment. Screening ...
No one wants a colonoscopy. But there's no getting around the lifesaving procedure -- the gold standard for colon cancer detection. With the development of the FIT test, or fecal immunochemical test, ...
I paused, and then I clicked "cancel appointment." The blood in my stool, the most common sign of colon cancer in young people, was going away. I chalked up my concerns to my job: I was interviewing ...